España | COVID-19 en 2021: vacunas disponibles y coste sanitario del rechazo a vacunación

Spain | COVID-19 during 2021: vaccines achieved and health cost of vaccine hesitancy

José Boscá, José Cano Leiva and Javier Ferri

No 22/03, Working Papers from BBVA Bank, Economic Research Department

Abstract: The health crisis triggered by the COVID-19 pandemic has evolved over the two years since the virus was first detected. In this Working Paper we analyze how this evolution has been in Spain during 2021. The health crisis triggered by the COVID-19 pandemic has evolved over the two years since the virus was first detected. In this Working Paper we analyze how this evolution has been in Spain during 2021.

Keywords: Pandemic; Pandemia; Vaccines; Vacunas; health crisis; crisis sanitaria; hospitals; hospitales; COVID-19; Covid-19; Spain; España; Regional Analysis Spain; Análisis Regional España; Working Papers; Documento de Trabajo (search for similar items in EconPapers)
JEL-codes: H12 I10 I18 (search for similar items in EconPapers)
Pages: 37 pages
Date: 2022-05
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.bbvaresearch.com/wp-content/uploads/20 ... n_during_2021_WB.pdf (application/pdf)
https://www.bbvaresearch.com/wp-content/uploads/20 ... n_during_2021_WB.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bbv:wpaper:2203

Access Statistics for this paper

More papers in Working Papers from BBVA Bank, Economic Research Department Contact information at EDIRC.
Bibliographic data for series maintained by OSCAR DE LAS PENAS SANCHEZ-CARO ().